Works matching IS 03331024 AND DT 2022 AND VI 42 AND IP 4/5
Results: 17
Board Walk - April 2022.
- Published in:
- 2022
- By:
- Publication type:
- Editorial
Board Walk.
- Published in:
- 2022
- By:
- Publication type:
- Editorial
Effect of antibody switch in non-responders to a CGRP receptor antibody treatment in migraine: A multi-center retrospective cohort study.
- Published in:
- Cephalalgia, 2022, v. 42, n. 4/5, p. 291, doi. 10.1177/03331024211048765
- By:
- Publication type:
- Article
Incidence of spontaneous intracranial hypotension in a community: Beverly Hills, California, 2006–2020.
- Published in:
- Cephalalgia, 2022, v. 42, n. 4/5, p. 312, doi. 10.1177/03331024211048510
- By:
- Publication type:
- Article
T2* reduction in patients with acute post-traumatic headache.
- Published in:
- Cephalalgia, 2022, v. 42, n. 4/5, p. 357, doi. 10.1177/03331024211048509
- By:
- Publication type:
- Article
TOP-PRO study: A randomized double-blind controlled trial of topiramate versus propranolol for prevention of chronic migraine.
- Published in:
- Cephalalgia, 2022, v. 42, n. 4/5, p. 396, doi. 10.1177/03331024211047454
- By:
- Publication type:
- Article
Clinical correlates of hypothalamic functional changes in migraine patients.
- Published in:
- Cephalalgia, 2022, v. 42, n. 4/5, p. 279, doi. 10.1177/03331024211046618
- By:
- Publication type:
- Article
Migraine evolution after the cessation of CGRP(-receptor) antibody prophylaxis: a prospective, longitudinal cohort study.
- Published in:
- Cephalalgia, 2022, v. 42, n. 4/5, p. 326, doi. 10.1177/03331024211046617
- By:
- Publication type:
- Article
No structural brain alterations in new daily persistent headache – a cross sectional VBM/SBM study.
- Published in:
- Cephalalgia, 2022, v. 42, n. 4/5, p. 335, doi. 10.1177/03331024211045653
- By:
- Publication type:
- Article
Polygenic risk provides biological validity for the ICHD-3 criteria among Finnish migraine families.
- Published in:
- Cephalalgia, 2022, v. 42, n. 4/5, p. 345, doi. 10.1177/03331024211045651
- By:
- Publication type:
- Article
Greater occipital nerve block in migraine may have a place in migraine treatment.
- Published in:
- 2022
- By:
- Publication type:
- Letter to the Editor
The influence of endogenous and exogenous hormonal factors on migraine in spontaneous postmenopausal women: A nationwide population-based study in South Korea.
- Published in:
- Cephalalgia, 2022, v. 42, n. 4/5, p. 376, doi. 10.1177/03331024211044441
- By:
- Publication type:
- Article
Time to retire 'New daily persistent headache': Mode of onset of chronic migraine and tension-type headache.
- Published in:
- Cephalalgia, 2022, v. 42, n. 4/5, p. 385, doi. 10.1177/03331024211044440
- By:
- Publication type:
- Article
Indirect costs attributed to headache: A nation-wide survey of an active working population.
- Published in:
- Cephalalgia, 2022, v. 42, n. 4/5, p. 317, doi. 10.1177/03331024211043795
- By:
- Publication type:
- Article
Headache in progressive facial hemiatrophy (Parry-Romberg syndrome): A paradigmatic case and systematic review of the literature.
- Published in:
- Cephalalgia, 2022, v. 42, n. 4/5, p. 409, doi. 10.1177/03331024211043452
- By:
- Publication type:
- Article
The characteristics of COVID-19 vaccine-related headache: Clues gathered from the healthcare personnel in the pandemic.
- Published in:
- Cephalalgia, 2022, v. 42, n. 4/5, p. 366, doi. 10.1177/03331024211042390
- By:
- Publication type:
- Article
Efficacy and safety of exogenous beta-hydroxybutyrate for preventive treatment in episodic migraine: A single-centred, randomised, placebo-controlled, double-blind crossover trial.
- Published in:
- Cephalalgia, 2022, v. 42, n. 4/5, p. 302, doi. 10.1177/03331024211043792
- By:
- Publication type:
- Article